Literature DB >> 7512482

Cardiovascular benefits of antihypertensive therapy postacute myocardial infarction. Therapeutic considerations.

P Sleight1.   

Abstract

Patients who survive a myocardial infarction are at high risk of future recurrent infarction, sudden death and other vascular events. While it is possible to predict many risks, it is not possible to predict reinfarction. Since reinfarction carries a poor prognosis we should attempt to reduce this risk in all patients who survive an acute myocardial infarction. This paper reviews the wide range of lifestyle modifications and pharmacological interventions aimed at improving the long term prognosis of patients who have suffered an acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7512482     DOI: 10.2165/00003495-199300462-00010

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  39 in total

1.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

2.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

3.  Calcium antagonists in secondary prevention after myocardial infarction.

Authors:  S Persson
Journal:  Drugs       Date:  1991       Impact factor: 9.546

4.  Effects of endurance training on baroreflex sensitivity and blood pressure in borderline hypertension.

Authors:  V K Somers; J Conway; J Johnston; P Sleight
Journal:  Lancet       Date:  1991-06-08       Impact factor: 79.321

5.  Comparison of baroreflex sensitivity and heart period variability after myocardial infarction.

Authors:  J T Bigger; M T La Rovere; R C Steinman; J L Fleiss; J N Rottman; L M Rolnitzky; P J Schwartz
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

6.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

7.  Risk stratification and survival after myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1983-08-11       Impact factor: 91.245

8.  Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.

Authors:  P R Rossi; S Yusuf; D Ramsdale; L Furze; P Sleight
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

9.  Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction.

Authors:  L E Daly; R Mulcahy; I M Graham; N Hickey
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-30

10.  Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.

Authors: 
Journal:  BMJ       Date:  1993-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.